mononuclear cells
Peripheral blood or bone marrow samples from 53 consecutive patients with newly diagnosed or relapsed AML were Introduction obtained prior to chemotherapy. Mononuclear cells were separated by density gradient centrifugation on Ficoll-Hypaque Several members of closely related receptor tyrosine kinases (Pharmacia, Uppsala, Sweden). These preparations contained (RTK), involved in angiogenesis, have recently been cloned at least 90% myeloblasts as judged by morphological criteria by virtue of their homology to the FMS oncogene, as has been on Papenheim smears. A control group of 15 healthy volunrecently reviewed. 1 They include FLT1 and KDR/FLK1 which teer bone marrow donors was included. are the receptors for vascular endothelial growth factor (VEGF). 2 A third RTK, FLT3, has been shown to be expressed by leukemia cells as has been reviewed in this journal. 3 FLT4, another member of this class of receptors, forms the high Preparation of CD 34-positive cells affinity binding site for VEGF-C. 4 The latter represents a novel angiogenic growth factor with sequence homology to VEGF Mononuclear cells from about 30 ml of bone marrow from and placenta growth factor (P1GF). 4 The genes coding for sevnormal human volunteers were recovered from a Ficolleral members of this class of RTKs such as FLT4, KIT, FMS, Hypaque gradient, washed twice and counted. To select for FLT3, PDGFRA have presumably been derived from a com-CD34-positive cells about 10 8 mononuclear cells were mon ancestor by duplications of immunoglobulin-like applied to the MiniMacs column (Miltenyi Biotech, Bergisch domains.
5 FLT4, like other RTKs, has been mapped to the long Gladbach, Germany) according to the directions of the suparm of chromosome 5. plier. Recovered cells were evaluated for purity by FACS Two transcripts of FLT4 with a size of 4.5 kb and 5.8 kb are analysis employing a CD34 monoclonal antibody recognizing expressed in adult and fetal tissues leading to a short and a a different epitope from the one used for the MiniMacs collong form of the FLT4 protein. 7, 8 The long form possesses 65 umn (Anti HPCA-2; Becton Dickinson, San Jose, CA, USA). additional amino acids including three tyrosine residues. One Purity of obtained cells was at least 93% (not shown). of these, tyrosine 1337, seems to be necessary for liganddependent transformation and signal transduction to the cytoplasmatic factors GRB2 and SHC. Controls included: blocking of anti-FLT4 antibody by specific peptide, replacement of primary and secondMononuclear cells were washed twice in PBS and collected by centrifugation. Total cellular RNA was prepared using ary antibody with PBS, visualization of peroxidase only, incubation of cells with normal rabbit serum (Sigma, Deisenhofen, Qiagen minicolumns (Qiagen, Hilden, Germany) as described by the manufacturer. One microgram of RNA was used for cGermany) in concentrations ranging from 0.1% to 0.01% instead of primary antiserum. DNA synthesis employing avian myeloblastosis virus (AMV) reverse transcriptase and oligo dT as primer. RT reactions were diluted to 100 l with distilled water and heated to 95°C for 10 min.
Results Different aliquots of c-DNA were amplified with specific primers for FLT4, VEGF-C and actin as control for successful FLT4 expression was studied with a sensitive nested RT-PCR reaction. The limit of detection is at least one FLT4-positive c-DNA synthesis. For FLT4 and VEGF-C two rounds and for actin one round of 35 cycles of PCR were performed in a cell in 10 5 bone marrow cells (data not shown). With this method c-DNA samples from bone marrow cells of 15 healthy programmable heat block at 94°C for 1.5 min, at 60°C for 3 min and at 72°C for 4 min. For the first round 1 l of the donors were investigated. None was positive for FLT4 expression. To confirm further the lack of FLT4 formation in RT reaction and for the second round of RCR 1 l of a 1:100 dilution of the first round was used. Five microliters of PCR normal bone marrow cells, CD34-positive cells were prepared by use of a mini MACS column from three additional normal products were separated on 1% agarose gels, stained with ethidium bromide and visualized under UV light. Primer donors yielding a suspension of CD34-positive cells of at least 93% purity (not shown). FLT4 specific amplification products sequences were as follows: FLT4: outer sense primer 5Ј-CTGCTGGAGGAAAAGTCTGG-3Ј; outer antisense primer 5Ј-were not found in the three samples ( Figure 1) . A series of 53 consecutive patients with AML and the leu-CTTGCAGAACTCCACGATCA-3Ј; inner sense primer 5Ј-CGTATCTGTGCAGCGTGTG-3Ј; inner antisense primer 5Ј-kemic cell lines KG1a, TF-1 and U937 were investigated for expression of FLT4 by PCR analysis. U937, but not TF-1 and GGTTGACCACGTTGAGGTG-3Ј; VEGF-C: outer sense primer 5Ј-AGCTAAGGAAAGGAGGCTGG-3Ј; outer antisense primer KG1a cells were found to be positive for FLT4 m-RNA. Fortyone samples originated from patients with de novo AML at 5Ј-TGTGTTTTCATCAAATTCTCGG-3Ј; inner sense primer 5Ј-TGAACACCAGCACGAGCTAC-3Ј; inner antisense primer 5Ј-diagnosis or at relapse and 12 samples from patients with secondary AML. From the 53 AML patients overall 34% CATAAAATCTTCCTGAGCCAGG-3Ј. Actin: sense primer 5Ј-CGCTGCGCTGGTCGTCGACA-3Ј; antisense primer 5Ј-expressed FLT4. A representative example of a PCR analysis is demonstrated in Figure 1 . Table 1 shows the relative per-GTCACGCACGATTTCCCGCT-3Ј. The size of the PCR products corresponds to 625 bp for FLT4 outer primer pair, centages of FLT4 positivity of AML samples according to FAB type. 500 bp inner primer pair, VEGF-C outer primer pair 764 bp, inner primer pair 269 bp and for actin 619 bp. To avoid crossThe cell lines U937 and TF-1 and leukemic blasts from eight patients were investigated for FLT4 protein expression contamination the set-up of PCR reactions and gel electrophoresis were carried out in different rooms using different sets of pipettes. Appropriate control reactions always remained negative. For each primer pair PCR products were subcloned using the TA cloning kit (Invitrogen, San Diego, CA, USA). Single bacterial colonies were picked and cultured overnight. Bacteria were diluted in distilled water and boiled for 10 min. PCR reactions were performed with primers recognizing sites flanking the PCR product (Dynal A and B; Dynal, Hamburg, Germany). Since one of the primers is biotinylated strand separation was carried out using streptavidin-coated Dynabeads (Dynal). DNA sequencing was performed with the Taq cycle sequencing kit (Applied Biosystems, Foster City, CA, USA) and the automated DNA sequencer 373A (Applied Biosystems). The identified DNA sequences corresponded to the published ones for all primer pairs.
Immunocytochemistry
Cells were transferred from culture into the chamber slides where they were washed twice with PBS for 10 min. Afterwards they were fixed for 15 min with fresh paraformaldehyde (4%) at room temperature. They were then washed in PBS and further processed for the visualisation of FLT4. Polyclonal antibodies against FLT4 were purchased from Santa Cruz peroxidase complex (ABC) techniques. The peroxidase FLT4 represents a recently cloned receptor for the angiogenic growth factor VEGF-C which has sequence homology to VEGF and P1GF. 4, 11 In the adult organism FLT4 expression seems to be restricted to a few tissues such as lymph endothelia and HEV. 10 On the other hand, FLT4 can be found in a variety of with immunocytochemistry using a modified APAP method. In concordance with the PCR analysis U937 cells were positumor cell lines including the leukemic cell line HEL. 12 We therefore studied FLT4 expression in normal bone marrow and tive for FLT4 protein expression. In Figure 2 photomicrographs of immunocytochemistry are shown from U937 cells and from leukemic blasts of 53 patients with AML. Using a sensitive nested PCR approach we were not able to detect FLT4 a patient with FAB M5 AML, both positive for FLT4 protein formation. Of the eight patients investigated four were positive transcripts in mononuclear cells from the bone marrow of 15 healthy volunteers. Neither was FLT4m-RNA found in cells and four were negative for FLT4 immunostaining. In six patients these results were concordant with PCR results. In one enriched in CD34-positive cells from three additional normal donors. In leukemic samples from 53 consecutive patients patient, PCR was positive and no protein expression was detected. In the other patient reverse results were found. In with AML, FLT4 expression was seen in 18 cases, correspond- 
